Animal Healthcare Market Size, Trends and Insights By Animal Type (Companion animal, Production animal), By Product (Pharmaceuticals, Vaccines, Medical feed additives, Equipment and disposables, Diagnostics, Others), By Distribution Channel (Ecommerce, Retail, Veterinary hospitals and clinics), By End User (Reference laboratories, Veterinary hospitals and clinics, Point of care testing, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Merck Animal Health
- Vetoquinol S.A.
- Zoetis
- Ceva Santé Animale
- Others
Reports Description
According to Custom Market Insights (CMI), The Global Animal Healthcare Market Size was valued at USD 44.76 billion in 2021 and is expected to reach USD 48.13 billion in 2022 and is estimated to reach USD 94.8 billion by the end of 2030 at a CAGR of approximately 10.7% during the forecast period 2022-2030.
The rapid increase in the demand for various food products and protein in the global market has boosted the need for a better animal healthcare system. The increasing number of diseases prevalent among animals has encouraged the key market players to introduce modern medicines into the market for treating animals. The pharmaceutical sector has introduced various vaccinations to prevent several animal diseases. Several industries have taken multiple steps to prevent infection among animals by controlling the pathogens and risk of food-borne illnesses. The outbreak of the pandemic had a considerable impact on the animal healthcare system. Steady growth was noticed during the course of the pandemic.
Growth Factors
The various initiatives taken up by the government have helped to boost the healthcare system for animals to a great extent. In addition, the rapid advancements in medicines and drugs, which have resulted from the constant research and development programs carried out by the key market players, have helped boost the Animal Healthcare Market.
The rapid increase in the demand for animal products that provide people with several health benefits has boosted the need for better healthcare management for animals. An increase in the number of people who own pets has also raised the demand for better animal healthcare management. Various therapies and services are carried out using animals as pets, encouraging a better healthcare system for animals. The increasing concentration on the multiple innovations regarding animal healthcare has strengthened the market’s growth and is expected to continue similarly during the forecast period.
Segmental Insights
Segmentation of the Animal Healthcare Market based on Product
Based on Product, the segment of pharmaceuticals has emerged as the largest market due to the massive demand and supply of pharmaceutical products worldwide for treating several diseases related to animals. The extensive market share held by this segment has emerged as the reason for its leading position in the market. This segment will continue its performance during the forecast period and the rapid advancements in animal-related drugs.
The pharmaceutical sector related to animal healthcare mainly deals with drugs that provide an anti-inflammatory action on the body, which is an almost common problem. The other drugs included under this segment are antibiotics and antiparasitic drugs, which physicians commonly use for treating various conditions related to animals. In addition, the rapid development of companion animal ownership emerged as a significant factor in the growth of the pharmaceutical sector, increasing the Animal Healthcare Market.
The key market players are conducting constant research and development programs intending to introduce modern medicines into the market that have a better effect on the health of the animals and produce minimum side effects. The increasing number of collaborations and deals between the key market players for expanding their business strategies and profits has encouraged the introduction of modern medicines into the market. The segment of veterinary diagnostics has emerged as the next largest segment due to the increasing number of diagnostic equipment and procedures adopted by the healthcare sector, which has, in turn, encouraged the expenditure on animal healthcare.
Segmentation of the Animal Healthcare Market based on Animal Type
Based on animal type, the segment of production animals has emerged as the largest market in the current scenario of the vast market share owned by this sector. The various government healthcare organizations are mainly responsible for developing this segment due to the prime concentration on food safety and sustainability. Food security has been considered a priority by policymakers worldwide, which has given rise to several regulations and rules imposed by the government. The rearing of livestock has also boosted over the period owing to the massive food production that is taking place.
The long term sustainability has been considered the primary focus by the policymakers, which can be supported with the help of improved productivity as well as greater concentration on veterinary healthcare for livestock. Furthermore, food products that are based on animals have been considered one of the largest markets due to the increasing demand for such products among people all over the world. In addition, the various health benefits obtained through animal-based food products have boosted the number of people who consume them.
The outbreak of the pandemic had a considerable impact on animal-based food products due to the misconceptions spread regarding the causation of infection during the pandemic. The various benefits that are obtained through pets have boosted this segment considerably. Emotional stability has been received by controlling anxiety with the help of a pet, and hence it emerges as a significant companion in the current situation. In addition, various therapies in which assistance has been obtained with the use of animals and their products have boosted this segment to a great extent.
Segmentation of the Animal Healthcare Market based on Distribution Channel
Based on the distribution channel, this segment of veterinary hospital pharmacy has emerged as the largest market due to the huge demand and supply of medicines and other pharmaceutical products experienced in the hospital sector. In addition, the various treatments and drugs required for certain animal conditions are mainly found in drug stores for animal products. Therefore, the devil’s ability to attach the healthcare sector to the pharmaceutical store emerges as a significant opportunity for boosting the demand and supply chain of drugs and medicines in the market.
The vast number of operative procedures in the hospital sector for animals demand several drugs and medicines used during surgical procedures. Such products are usually available in the pharmacies attached to the hospital sector. The segment of eCommerce and retail channels has also contributed significantly to the growth of the animal healthcare sector owing to the increasing demand for various drugs and medicines over the online platform. The online platform provides excellent convenience to pet owners by providing them with the necessary drugs and medications by letting them be in their comfort zone.
A considerable number of patients have been observed who do not want to purchase drugs and medicines from retail pharmacies, which helps the segment of online pharmacies to show tremendous growth over the period. Furthermore, the various offers schemes provided by the online platforms for attracting potential consumers have also emerged as a significant opportunity for developing this segment under the animal healthcare category. Therefore, the part of retail pharmacies is expected to show considerable growth in the long run about the increased adoption of animals by people.
Segmentation of the Animal Healthcare Market based on End Users
Based on end-user, the segment of veterinary hospitals has emerged as the largest market as it is the most common sector visited by pet owners in the event of an injury or significant disease. In addition, the lack of drugs for animals in regular retail drugstores boosts the demand for a suitable hospital for animals. Usually, the number of veterinary services is minimal, vastly boosting the veterinary hospital segment’s growth.
The rapid improvements observed in the facilities and services provided by the hospital and clinics have attracted potential consumers over time. The availability of various services and facilities within the hospital sector makes it easier for pet owners to take care of their animals. In addition, various government initiatives have been taken to improve animal healthcare facilities. This has boosted the growth of the hospital segment considerably over some time.
Report Scope
| Feature of the Report | Details |
| Market Size in 2021 | USD 44.76 Billion |
| Projected Market Size in 2030 | USD 94.8 Billion |
| CAGR Growth Rate | 10.7% CAGR (2022-2030) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Prominent Players | Merck Animal Health, Vetoquinol S.A., Zoetis, Ceva Santé Animale, Boehringer Ingelheim GmbH, IDEXX, Heska Corporation, Virbac, Elanco, B.Braun Vet Care, Televet, Mars Inc., Covetous, DRE Veterinary, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Thermo Fisher Scientific Inc., IDVet, Bimeda Inc., Midmark Corporation, and Others |
| Key Segment | By Animal Type, Product, Distribution Channel, End User, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfill your requirements for research. |
Regional Insights
Based on geography, the region of North America has emerged as the largest Animal Healthcare Market due to the government’s massive number of services and facilities. In addition, the government has taken various steps to improve the healthcare facilities provided to the animals to maintain their health.
The various technological advancements which are taking place in this geographical region have also emerged as a significant reason for the growth of the animal healthcare system. As a result, the key market players in this region have emerged as major growth factors for the healthcare system in the market. Furthermore, the rapid research and development programs carried out by the key market players in this region have helped them introduce new medicines into the market, which have better results on the health of the animals and produce minimum side effects over the period.
The region of Asia Pacific has also emerged as a massive market for animal healthcare systems resulting from the constant research and development programs carried out by the key market players and the vast investment made by them for improving the various facilities provided to the animals. In addition, the use of branded and generic drugs for treatment has significantly boosted animal healthcare growth.
Recent Developments
- Bayer has acquired Elanco Limited to enhance the distribution channel of the various products manufactured by the company. This deal has helped the pharmaceutical sector earn more profits over time.
- In April 2021 – Hester Biosciences introduced different herbal veterinary products on the market.
Key Players
- Merck Animal Health
- Vetoquinol S.A.
- Zoetis
- Ceva Santé Animale
- BoehringerIngelheim GmbH
- IDEXX
- Heska Corporation
- Virbac
- Elanco
- Braun Vet Care
- Televet
- Mars Inc.
- Covetrus
- DRE Veterinary
- Phibro Animal Health Corporation
- Dechra Pharmaceuticals PLC
- Thermo Fisher Scientific Inc.
- IDVet
- Bimeda Inc.
- Midmark Corporation
Segments covered in the report
By Animal Type
- Companion animal
- Production animal
By Product
- Pharmaceuticals
- Vaccines
- Medical feed additives
- Equipment and disposables
- Diagnostics
- Others
By Distribution Channel
- E-commerce
- Retail
- Veterinary hospitals and clinics
By End User
- Reference laboratories
- Veterinary hospitals and clinics
- Point of care testing
- Others
On the basis of Geography
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Animal Healthcare Market, (2022 – 2030) (USD Billion)
- 2.2 Global Animal Healthcare Market : snapshot
- Chapter 3. Global Animal Healthcare Market – Industry Analysis
- 3.1 Animal Healthcare Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Constant Research And Development Programs
- 3.2.2 Initiatives Taken Up By The Government
- 3.2.3 Increase In The Demand For Animal Products
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Animal Type
- 3.7.2 Market attractiveness analysis By Product
- 3.7.3 Market attractiveness analysis By Distribution Channel
- 3.7.4 Market attractiveness analysis By End User
- Chapter 4. Global Animal Healthcare Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Animal Healthcare Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Animal Healthcare Market – Animal Type Analysis
- 5.1 Global Animal Healthcare Market overview: By Animal Type
- 5.1.1 Global Animal Healthcare Market share, By Animal Type, 2021 and 2030
- 5.2 Companion animal
- 5.2.1 Global Animal Healthcare Market by Companion animal, 2022 – 2030 (USD Billion)
- 5.3 Production animal
- 5.3.1 Global Animal Healthcare Market by Production animal, 2022 – 2030 (USD Billion)
- 5.1 Global Animal Healthcare Market overview: By Animal Type
- Chapter 6. Global Animal Healthcare Market – Product Analysis
- 6.1 Global Animal Healthcare Market overview: By Product
- 6.1.1 Global Animal Healthcare Market share, By Product, 2021 and 2030
- 6.2 Pharmaceuticals
- 6.2.1 Global Animal Healthcare Market by Pharmaceuticals, 2022 – 2030 (USD Billion)
- 6.3 Vaccines
- 6.3.1 Global Animal Healthcare Market by Vaccines, 2022 – 2030 (USD Billion)
- 6.4 Medical feed additives
- 6.4.1 Global Animal Healthcare Market by Medical feed additives, 2022 – 2030 (USD Billion)
- 6.5 Equipment and disposables
- 6.5.1 Global Animal Healthcare Market by Equipment and disposables, 2022 – 2030 (USD Billion)
- 6.6 Diagnostics
- 6.6.1 Global Animal Healthcare Market by Diagnostics, 2022 – 2030 (USD Billion)
- 6.1 Global Animal Healthcare Market overview: By Product
- Chapter 7. Global Animal Healthcare Market – Distribution Channel Analysis
- 7.1 Global Animal Healthcare Market overview: By Distribution Channel
- 7.1.1 Global Animal Healthcare Market share, By Distribution Channel, 2021 and 2030
- 7.2 Ecommerce
- 7.2.1 Global Animal Healthcare Market by Ecommerce, 2022 – 2030 (USD Billion)
- 7.3 Retail
- 7.3.1 Global Animal Healthcare Market by Retail, 2022 – 2030 (USD Billion)
- 7.4 Veterinary hospitals and clinics
- 7.4.1 Global Animal Healthcare Market by Veterinary hospitals and clinics, 2022 – 2030 (USD Billion)
- 7.1 Global Animal Healthcare Market overview: By Distribution Channel
- Chapter 8. Global Animal Healthcare Market – End User Analysis
- 8.1 Global Animal Healthcare Market overview: By End User
- 8.1.1 Global Animal Healthcare Market share, By End User, 2021 and 2030
- 8.2 Reference laboratories
- 8.2.1 Global Animal Healthcare Market by Reference laboratories, 2022 – 2030 (USD Billion)
- 8.3 Veterinary hospitals and clinics
- 8.3.1 Global Animal Healthcare Market by Veterinary hospitals and clinics, 2022 – 2030 (USD Billion)
- 8.4 Point of care testing
- 8.4.1 Global Animal Healthcare Market by Point of care testing, 2022 – 2030 (USD Billion)
- 8.1 Global Animal Healthcare Market overview: By End User
- Chapter 9. Animal Healthcare Industry – Regional Analysis
- 9.1 Global Animal Healthcare Industry Regional Overview
- 9.2 Global Animal Healthcare Industry Share, by Region, 2021 & 2030 (USD Billion)
- 9.3. North America
- 9.3.1 North America Animal Healthcare Industry, 2022 – 2030 (USD Billion)
- 9.3.1.1 North America Animal Healthcare Industry, by Country, 2022 – 2030 (USD Billion)
- 9.3.1 North America Animal Healthcare Industry, 2022 – 2030 (USD Billion)
- 9.4 North America Animal Healthcare Industry, by Animal Type, 2022 – 2030
- 9.4.1 North America Animal Healthcare Industry, by Animal Type, 2022 – 2030 (USD Billion)
- 9.5 North America Animal Healthcare Industry, by Product, 2022 – 2030
- 9.5.1 North America Animal Healthcare Industry, by Product, 2022 – 2030 (USD Billion)
- 9.6 North America Animal Healthcare Industry, by Distribution Channel, 2022 – 2030
- 9.6.1 North America Animal Healthcare Industry, by Distribution Channel, 2022 – 2030 (USD Billion)
- 9.7 North America Animal Healthcare Industry, by End User, 2022 – 2030
- 9.7.1 North America Animal Healthcare Industry, by End User, 2022 – 2030 (USD Billion)
- 9.8. Europe
- 9.8.1 Europe Animal Healthcare Industry, 2022 – 2030 (USD Billion)
- 9.8.1.1 Europe Animal Healthcare Industry, by Country, 2022 – 2030 (USD Billion)
- 9.8.1 Europe Animal Healthcare Industry, 2022 – 2030 (USD Billion)
- 9.9 Europe Animal Healthcare Industry, by Animal Type, 2022 – 2030
- 9.9.1 Europe Animal Healthcare Industry, by Animal Type, 2022 – 2030 (USD Billion)
- 9.10 Europe Animal Healthcare Industry, by Product, 2022 – 2030
- 9.10.1 Europe Animal Healthcare Industry, by Product, 2022 – 2030 (USD Billion)
- 9.11 Europe Animal Healthcare Industry, by Distribution Channel, 2022 – 2030
- 9.11.1 Europe Animal Healthcare Industry, by Distribution Channel, 2022 – 2030 (USD Billion)
- 9.12 Europe Animal Healthcare Industry, by End User, 2022 – 2030
- 9.12.1 Europe Animal Healthcare Industry, by End User, 2022 – 2030 (USD Billion)
- 9.13. Asia Pacific
- 9.13.1 Asia Pacific Animal Healthcare Industry, 2022 – 2030 (USD Billion)
- 9.13.1.1 Asia Pacific Animal Healthcare Industry, by Country, 2022 – 2030 (USD Billion)
- 9.13.1 Asia Pacific Animal Healthcare Industry, 2022 – 2030 (USD Billion)
- 9.14 Asia Pacific Animal Healthcare Industry, by Animal Type, 2022 – 2030
- 9.14.1 Asia Pacific Animal Healthcare Industry, by Animal Type, 2022 – 2030 (USD Billion)
- 9.15 Asia Pacific Animal Healthcare Industry, by Product, 2022 – 2030
- 9.15.1 Asia Pacific Animal Healthcare Industry, by Product, 2022 – 2030 (USD Billion)
- 9.16 Asia Pacific Animal Healthcare Industry, by Distribution Channel, 2022 – 2030
- 9.16.1 Asia Pacific Animal Healthcare Industry, by Distribution Channel, 2022 – 2030 (USD Billion)
- 9.17 Asia Pacific Animal Healthcare Industry, by End User, 2022 – 2030
- 9.17.1 Asia Pacific Animal Healthcare Industry, by End User, 2022 – 2030 (USD Billion)
- 9.18. Latin America
- 9.18.1 Latin America Animal Healthcare Industry, 2022 – 2030 (USD Billion)
- 9.18.1.1 Latin America Animal Healthcare Industry, by Country, 2022 – 2030 (USD Billion)
- 9.18.1 Latin America Animal Healthcare Industry, 2022 – 2030 (USD Billion)
- 9.19 Latin America Animal Healthcare Industry, by Animal Type, 2022 – 2030
- 9.19.1 Latin America Animal Healthcare Industry, by Animal Type, 2022 – 2030 (USD Billion)
- 9.20 Latin America Animal Healthcare Industry, by Product, 2022 – 2030
- 9.20.1 Latin America Animal Healthcare Industry, by Product, 2022 – 2030 (USD Billion)
- 9.21 Latin America Animal Healthcare Industry, by Distribution Channel, 2022 – 2030
- 9.21.1 Latin America Animal Healthcare Industry, by Distribution Channel, 2022 – 2030 (USD Billion)
- 9.22 Latin America Animal Healthcare Industry, by End User, 2022 – 2030
- 9.22.1 Latin America Animal Healthcare Industry, by End User, 2022 – 2030 (USD Billion)
- 9.23. The Middle-East and Africa
- 9.23.1 The Middle-East and Africa Animal Healthcare Industry, 2022 – 2030 (USD Billion)
- 9.23.1.1 The Middle-East and Africa Animal Healthcare Industry, by Country, 2022 – 2030 (USD Billion)
- 9.23.1 The Middle-East and Africa Animal Healthcare Industry, 2022 – 2030 (USD Billion)
- 9.24 The Middle-East and Africa Animal Healthcare Industry, by Animal Type, 2022 – 2030
- 9.24.1 The Middle-East and Africa Animal Healthcare Industry, by Animal Type, 2022 – 2030 (USD Billion)
- 9.25 The Middle-East and Africa Animal Healthcare Industry, by Product, 2022 – 2030
- 9.25.1 The Middle-East and Africa Animal Healthcare Industry, by Product, 2022 – 2030 (USD Billion)
- 9.26 The Middle-East and Africa Animal Healthcare Industry, by Distribution Channel, 2022 – 2030
- 9.26.1 The Middle-East and Africa Animal Healthcare Industry, by Distribution Channel, 2022 – 2030 (USD Billion)
- 9.27 The Middle-East and Africa Animal Healthcare Industry, by End User, 2022 – 2030
- 9.27.1 The Middle-East and Africa Animal Healthcare Industry, by End User, 2022 – 2030 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 Merck Animal Health
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Vetoquinol S.A.
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Zoetis
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Ceva Santé Animale
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Boehringer Ingelheim GmbH
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 IDEXX
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Heska Corporation
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Virbac
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Elanco
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 B.Braun Vet Care
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Televet
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Mars Inc.
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Covetous
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 DRE Veterinary
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 Phibro Animal Health Corporation
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Dechra Pharmaceuticals PLC
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.17 Thermo Fisher Scientific Inc.
- 10.17.1 Overview
- 10.17.2 Financials
- 10.17.3 Product Portfolio
- 10.17.4 Business Strategy
- 10.17.5 Recent Developments
- 10.18 IDVet
- 10.18.1 Overview
- 10.18.2 Financials
- 10.18.3 Product Portfolio
- 10.18.4 Business Strategy
- 10.18.5 Recent Developments
- 10.19 Bimeda Inc.
- 10.19.1 Overview
- 10.19.2 Financials
- 10.19.3 Product Portfolio
- 10.19.4 Business Strategy
- 10.19.5 Recent Developments
- 10.20 Midmark Corporation
- 10.20.1 Overview
- 10.20.2 Financials
- 10.20.3 Product Portfolio
- 10.20.4 Business Strategy
- 10.20.5 Recent Developments
- 10.1 Merck Animal Health
List Of Figures
Figures No 1 to 31
List Of Tables
Tables No 1 to 102
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2030
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Key Players
- Merck Animal Health
- Vetoquinol S.A.
- Zoetis
- Ceva Santé Animale
- BoehringerIngelheim GmbH
- IDEXX
- Heska Corporation
- Virbac
- Elanco
- Braun Vet Care
- Televet
- Mars Inc.
- Covetrus
- DRE Veterinary
- Phibro Animal Health Corporation
- Dechra Pharmaceuticals PLC
- Thermo Fisher Scientific Inc.
- IDVet
- Bimeda Inc.
- Midmark Corporation
- Others
FAQs
“North America” region will lead the global Animal Health Care market during the forecast period 2022 to 2030.
The key factors driving the market [Growth Factors].
The key players operating in the Animal Health Care market are Merck Animal Health, Vetoquinol S.A., Zoetis, Ceva Santé Animale, BoehringerIngelheim GmbH, IDEXX, Heska Corporation, Virbac, Elanco, B.Braun Vet Care, Televet, Mars Inc., Covetrus, DRE Veterinary, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Thermo Fisher Scientific Inc., IDVet, Bimeda Inc., Midmark Corporation.
The global Animal Health Care market is expanding growth with a CAGR of approximately 4.3% during the forecast period (2022 to 2030).
The global Animal Health Care market size was valued at USD 42.3 Billion in 2021 and it is projected to reach around USD 66.5 Billion by 2030.